Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.
2.

Posthospital Fall Injuries and 30-Day Readmissions in Adults 65 Years and Older.

Hoffman GJ, Liu H, Alexander NB, Tinetti M, Braun TM, Min LC.

JAMA Netw Open. 2019 May 3;2(5):e194276. doi: 10.1001/jamanetworkopen.2019.4276.

PMID:
31125100
3.

Intraoperative Depth of Invasion Is Accurate in Early-Stage Oral Cavity Squamous Cell Carcinoma.

Moe J, McHugh JB, Udager AM, Braun TM, Helman JI, Ward BB.

J Oral Maxillofac Surg. 2019 Feb 20. pii: S0278-2391(19)30228-9. doi: 10.1016/j.joms.2019.02.016. [Epub ahead of print]

PMID:
30878591
4.

Extending Tests of Random Effects to Assess for Measurement Invariance in Factor Models.

Zhang Z, Braun TM, Peterson KE, Hu H, Téllez-Rojo MM, Sánchez BN.

Stat Biosci. 2018 Dec;10(3):634-650. doi: 10.1007/s12561-018-9222-7. Epub 2018 Sep 29.

PMID:
30805035
5.

Accuracy, Safety, and Reliability of Novel Phase I Designs-Letter.

Wages NA, Braun TM.

Clin Cancer Res. 2018 Nov 1;24(21):5482. doi: 10.1158/1078-0432.CCR-18-2090. No abstract available.

PMID:
30385655
6.

Increased Presence of Perineural Invasion in the Tongue and Floor of the Mouth: Could It Represent a More Aggressive Oral Squamous Cell Carcinoma, or Do Larger Aggressive Tumors Cause Perineural Invasion?

Kim RY, Helman JI, Braun TM, Ward BB.

J Oral Maxillofac Surg. 2019 Apr;77(4):852-858. doi: 10.1016/j.joms.2018.07.023. Epub 2018 Jul 27.

PMID:
30142323
7.

A Bayesian analysis of small n sequential multiple assignment randomized trials (snSMARTs).

Wei B, Braun TM, Tamura RN, Kidwell KM.

Stat Med. 2018 Nov 20;37(26):3723-3732. doi: 10.1002/sim.7900. Epub 2018 Jul 16.

PMID:
30010207
8.

The Effect of the 2009 USPSTF breast cancer screening recommendations on breast cancer in Michigan: A longitudinal study.

Caughran J, Braun TM, Breslin TM, Smith DR, Kreinbrink JL, Parish GK, Davis AT, Bacon-Baguley TA, Silver SM, Henry NL.

Breast J. 2018 Sep;24(5):730-737. doi: 10.1111/tbj.13034. Epub 2018 May 21.

PMID:
29785764
9.

Modeling adverse event counts in phase I clinical trials of a cytotoxic agent.

Muenz DG, Braun TM, Taylor JM.

Clin Trials. 2018 Aug;15(4):386-397. doi: 10.1177/1740774518772309. Epub 2018 May 19.

PMID:
29779418
10.

Motivating sample sizes in adaptive Phase I trials via Bayesian posterior credible intervals.

Braun TM.

Biometrics. 2018 Sep;74(3):1065-1071. doi: 10.1111/biom.12872. Epub 2018 Mar 13.

PMID:
29534298
11.

Variation in the use of advanced imaging at the time of breast cancer diagnosis in a statewide registry.

Henry NL, Braun TM, Breslin TM, Gorski DH, Silver SM, Griggs JJ.

Cancer. 2017 Aug 1;123(15):2975-2983. doi: 10.1002/cncr.30674. Epub 2017 Mar 16.

12.

Correlating the depth of invasion at specific anatomic locations with the risk for regional metastatic disease to lymph nodes in the neck for oral squamous cell carcinoma.

Brockhoff HC 2nd, Kim RY, Braun TM, Skouteris C, Helman JI, Ward BB.

Head Neck. 2017 May;39(5):974-979. doi: 10.1002/hed.24724. Epub 2017 Feb 25.

13.

Statistical controversies in clinical research: building the bridge to phase II-efficacy estimation in dose-expansion cohorts.

Boonstra PS, Braun TM, Taylor JMG, Kidwell KM, Bellile EL, Daignault S, Zhao L, Griffith KA, Lawrence TS, Kalemkerian GP, Schipper MJ.

Ann Oncol. 2017 Jul 1;28(7):1427-1435. doi: 10.1093/annonc/mdx045.

14.

Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.

Miller HK, Braun TM, Stillwell T, Harris AC, Choi S, Connelly J, Couriel D, Goldstein S, Kitko CL, Magenau J, Pawarode A, Reddy P, Riwes M, Yanik GA, Levine JE.

Biol Blood Marrow Transplant. 2017 Mar;23(3):522-528. doi: 10.1016/j.bbmt.2016.12.630. Epub 2016 Dec 22.

15.

Associations between use of the 21-gene recurrence score assay and chemotherapy regimen selection in a statewide registry.

Henry NL, Braun TM, Ali HY, Munir K, Silver SM, Gorski DH, Breslin TM, Griggs JJ.

Cancer. 2017 May 15;123(6):948-956. doi: 10.1002/cncr.30429. Epub 2016 Oct 27.

16.

Correlation of Lymph Node Density With Negative Outcome Predictors in Oral and Maxillofacial Squamous Cell Carcinoma.

Kim RY, Ward BB, Brockhoff HC 2nd, Helman JI, Braun TM, Skouteris CA.

J Oral Maxillofac Surg. 2016 Oct;74(10):2081-4. doi: 10.1016/j.joms.2016.03.023. Epub 2016 Mar 28.

PMID:
27102923
17.

Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.

Petrie JG, Ohmit SE, Truscon R, Johnson E, Braun TM, Levine MZ, Eichelberger MC, Monto AS.

J Infect Dis. 2016 Oct 15;214(8):1142-9. doi: 10.1093/infdis/jiw105. Epub 2016 Apr 19.

PMID:
27095420
18.

In Reply.

Dashow JE, McHugh JB, Braun TM, Edwards SP, Helman JI, Ward BB.

J Oral Maxillofac Surg. 2016 Jun;74(6):1104. doi: 10.1016/j.joms.2016.01.057. Epub 2016 Mar 7. No abstract available.

PMID:
26963075
19.

Effects of triclosan on host response and microbial biomarkers during experimental gingivitis.

Pancer BA, Kott D, Sugai JV, Panagakos FS, Braun TM, Teles RP, Giannobile WV, Kinney JS.

J Clin Periodontol. 2016 May;43(5):435-44. doi: 10.1111/jcpe.12519. Epub 2016 Apr 6.

20.

A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.

Levine JE, Braun TM, Harris AC, Holler E, Taylor A, Miller H, Magenau J, Weisdorf DJ, Ho VT, Bolaños-Meade J, Alousi AM, Ferrara JL; Blood and Marrow Transplant Clinical Trials Network.

Lancet Haematol. 2015 Jan;2(1):e21-9. doi: 10.1016/S2352-3026(14)00035-0. Epub 2014 Dec 23.

21.

Missed Opportunities for Transcranial Doppler Screening Among Children With Sickle Cell Disease.

Reeves SL, Fullerton HJ, Cohn LM, Dombkowski KJ, Boulton ML, Braun TM, Lisabeth LD.

Clin Pediatr (Phila). 2016 Oct;55(12):1093-9. doi: 10.1177/0009922815614351. Epub 2015 Nov 4.

PMID:
26538586
22.

Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series.

Pawarode A, Mineishi S, Reddy P, Braun TM, Khaled YA, Choi SW, Magenau JM, Harris AC, Connelly JA, Kitko CL, Parkin BL, Goldstein SC, Yanik GA, Levine JE, Ferrara JL, Couriel DR.

Biol Blood Marrow Transplant. 2016 Jan;22(1):54-60. doi: 10.1016/j.bbmt.2015.07.021. Epub 2015 Jul 26.

23.

Tests for time-invariant correlation of longitudinally measured biomarkers.

Chen S, Braun TM.

Stat Med. 2015 Dec 20;34(29):3888-900. doi: 10.1002/sim.6580. Epub 2015 Jul 14.

PMID:
26172451
24.

A two-dimensional biased coin design for dual-agent dose-finding trials.

Sun Z, Braun TM.

Clin Trials. 2015 Dec;12(6):596-607. doi: 10.1177/1740774515592404. Epub 2015 Jul 10.

PMID:
26163309
25.

Significantly Decreased Recurrence Rates in Keratocystic Odontogenic Tumor With Simple Enucleation and Curettage Using Carnoy's Versus Modified Carnoy's Solution.

Dashow JE, McHugh JB, Braun TM, Edwards SP, Helman JI, Ward BB.

J Oral Maxillofac Surg. 2015 Nov;73(11):2132-5. doi: 10.1016/j.joms.2015.05.005. Epub 2015 May 20.

PMID:
26044601
26.

The current design of oncology phase I clinical trials: progressing from algorithms to statistical models.

Braun TM.

Chin Clin Oncol. 2014 Mar;3(1):2. doi: 10.3978/j.issn.2304-3865.2014.02.01.

27.

Counterpoint: Risk factors, including genetic information, add value in stratifying patients for optimal preventive dental care.

Braun TM, Doucette-Stamm L, Duff GW, Kornman KS, Giannobile WV.

J Am Dent Assoc. 2015 Mar;146(3):174-8. doi: 10.1016/j.adaj.2015.01.014.

PMID:
25726344
28.

A statistical evaluation of dose expansion cohorts in phase I clinical trials.

Boonstra PS, Shen J, Taylor JM, Braun TM, Griffith KA, Daignault S, Kalemkerian GP, Lawrence TS, Schipper MJ.

J Natl Cancer Inst. 2015 Feb 20;107(3). pii: dju429. doi: 10.1093/jnci/dju429. Print 2015 Mar.

29.

Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes.

Gleimer M, Li Y, Chang L, Paczesny S, Hanauer DA, Frame DG, Byersdorfer CA, Reddy PR, Braun TM, Choi SW.

Bone Marrow Transplant. 2015 Mar;50(3):402-10. doi: 10.1038/bmt.2014.280. Epub 2014 Dec 22.

30.

Physician attitude, awareness, and knowledge regarding guidelines for transcranial Doppler screening in sickle cell disease.

Reeves SL, Fullerton HJ, Dombkowski KJ, Boulton ML, Braun TM, Lisabeth LD.

Clin Pediatr (Phila). 2015 Apr;54(4):336-45. doi: 10.1177/0009922814553429. Epub 2014 Oct 15.

PMID:
25320061
31.

The role of neighborhoods in the receipt of transcranial Doppler screening among children with sickle cell disease.

Reeves SL, Braun TM, Dombkowski KJ, Fullerton HJ, Boulton ML, Lisabeth LD.

J Pediatr Hematol Oncol. 2015 May;37(4):269-73. doi: 10.1097/MPH.0000000000000266.

PMID:
25265467
32.

Relationships between masticatory rhythmicity, body mass and cephalometrically-determined aesthetic and functional variables during development in humans.

Gerstner GE, Madhavan S, Braun TM.

Arch Oral Biol. 2014 Jul;59(7):711-21. doi: 10.1016/j.archoralbio.2014.04.011. Epub 2014 Apr 20.

PMID:
24798980
33.

Surgical periodontal therapy with and without initial scaling and root planing in the management of chronic periodontitis: a randomized clinical trial.

Aljateeli M, Koticha T, Bashutski J, Sugai JV, Braun TM, Giannobile WV, Wang HL.

J Clin Periodontol. 2014 Jul;41(7):693-700. doi: 10.1111/jcpe.12259.

34.

A Generalized Continual Reassessment Method for Two-Agent Phase I Trials.

Braun TM, Jia N.

Stat Biopharm Res. 2013 Jan 1;5(2):105-115. No abstract available.

35.

Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.

Kitko CL, Levine JE, Storer BE, Chai X, Fox DA, Braun TM, Couriel DR, Martin PJ, Flowers ME, Hansen JA, Chang L, Conlon M, Fiema BJ, Morgan R, Pongtornpipat P, Lamiman K, Ferrara JL, Lee SJ, Paczesny S.

Blood. 2014 Jan 30;123(5):786-93. doi: 10.1182/blood-2013-08-520072. Epub 2013 Dec 20.

36.

Parents' dental anxiety and oral health literacy: effects on parents' and children's oral health-related experiences.

Shin WK, Braun TM, Inglehart MR.

J Public Health Dent. 2014 Summer;74(3):195-201. doi: 10.1111/jphd.12046. Epub 2013 Dec 11.

37.

Crevicular fluid biomarkers and periodontal disease progression.

Kinney JS, Morelli T, Oh M, Braun TM, Ramseier CA, Sugai JV, Giannobile WV.

J Clin Periodontol. 2014 Feb;41(2):113-120. doi: 10.1111/jcpe.12194. Epub 2013 Dec 12.

38.

A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients.

Zhang J, Braun TM.

J Am Stat Assoc. 2013 Jan 1;108(503). doi: 10.1080/01621459.2013.806927.

39.

Using joint utilities of the times to response and toxicity to adaptively optimize schedule-dose regimes.

Thall PF, Nguyen HQ, Braun TM, Qazilbash MH.

Biometrics. 2013 Sep;69(3):673-82. doi: 10.1111/biom.12065. Epub 2013 Aug 19.

40.

ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

Vander Lugt MT, Braun TM, Hanash S, Ritz J, Ho VT, Antin JH, Zhang Q, Wong CH, Wang H, Chin A, Gomez A, Harris AC, Levine JE, Choi SW, Couriel D, Reddy P, Ferrara JL, Paczesny S.

N Engl J Med. 2013 Aug 8;369(6):529-39. doi: 10.1056/NEJMoa1213299.

41.

Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality.

Levine JE, Huber E, Hammer ST, Harris AC, Greenson JK, Braun TM, Ferrara JL, Holler E.

Blood. 2013 Aug 22;122(8):1505-9. doi: 10.1182/blood-2013-02-485813. Epub 2013 Jun 12.

42.

Patient stratification for preventive care in dentistry.

Giannobile WV, Braun TM, Caplis AK, Doucette-Stamm L, Duff GW, Kornman KS.

J Dent Res. 2013 Aug;92(8):694-701. doi: 10.1177/0022034513492336. Epub 2013 Jun 10.

43.

Clinical, microbiological, and salivary biomarker profiles of dental implant patients with type 2 diabetes.

Tatarakis N, Kinney JS, Inglehart M, Braun TM, Shelburne C, Lang NP, Giannobile WV, Oh TJ.

Clin Oral Implants Res. 2014 Jul;25(7):803-12. doi: 10.1111/clr.12139. Epub 2013 Feb 27.

44.

An improved quadratic inference function for parameter estimation in the analysis of correlated data.

Westgate PM, Braun TM.

Stat Med. 2013 Aug 30;32(19):3260-73. doi: 10.1002/sim.5715. Epub 2012 Dec 28.

45.

A Phase I/II trial design when response is unobserved in subjects with dose-limiting toxicity.

Braun TM, Kang S, Taylor JM.

Stat Methods Med Res. 2016 Apr;25(2):659-73. doi: 10.1177/0962280212464541. Epub 2012 Nov 1.

46.

Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes.

Harris AC, Kitko CL, Couriel DR, Braun TM, Choi SW, Magenau J, Mineishi S, Pawarode A, Yanik G, Levine JE.

Haematologica. 2013 Feb;98(2):179-84. doi: 10.3324/haematol.2012.073189. Epub 2012 Oct 12.

47.

Adaptive prior variance calibration in the Bayesian continual reassessment method.

Zhang J, Braun TM, Taylor JM.

Stat Med. 2013 Jun 15;32(13):2221-34. doi: 10.1002/sim.5621. Epub 2012 Sep 17.

48.

Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial.

Kaigler D, Pagni G, Park CH, Braun TM, Holman LA, Yi E, Tarle SA, Bartel RL, Giannobile WV.

Cell Transplant. 2013;22(5):767-77.

49.

Systemic Teriparatide Administration Promotes Osseous Regeneration of an Intrabony Defect: A Case Report.

Bashutski JD, Kinney JS, Benavides E, Maitra S, Braun TM, Giannobile WV, McCauley LK, Eber RM.

Clin Adv Periodontics. 2012 May;2(2):66-71.

50.

The effect of cluster size imbalance and covariates on the estimation performance of quadratic inference functions.

Westgate PM, Braun TM.

Stat Med. 2012 Sep 10;31(20):2209-22. doi: 10.1002/sim.5329. Epub 2012 Mar 13.

Supplemental Content

Loading ...
Support Center